New approach to specific Alzheimer's disease diagnosis based on plasma biomarkers in a cognitive disorder cohort.

Journal: European journal of clinical investigation
Published Date: Mar 22, 2025

Abstract

BACKGROUND: The validation of a combination of plasma biomarkers and demographic variables is required to establish reliable cut-offs for Alzheimer's disease diagnosis (AD).

Authors

  • Lourdes Álvarez-Sánchez
    Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
  • Laura Ferré-González
    Alzheimer's Disease Research Group, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
  • Carmen Peña-Bautista
    Neonatal Research Unit, Health Research Institute La Fe, Valencia, Spain.
  • Ángel Balaguer
    Plataforma de Big Data, IA y Bioestadística, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
  • Julián Luis Amengual
    Plataforma de Big Data, IA y Bioestadística, Instituto de Investigación Sanitaria La Fe, Valencia, Spain.
  • Miguel Baquero
    Neurology Unit, University and Polytechnic Hospital La Fe, Valencia, Spain.
  • Laura Cubas
    Division of Neuroinmunology, University and Polytechnic Hospital La Fe, Valencia, Spain.
  • Bonaventura Casanova
    Division of Neuroinmunology, University and Polytechnic Hospital La Fe, Valencia, Spain.
  • Consuelo Cháfer-Pericás
    Neonatal Research Unit, Health Research Institute La Fe, Valencia, Spain. Electronic address: m.consuelo.chafer@uv.es.

Keywords

External Resources

Popular Topics
Recent Journals